Levetiracetam AET 750 mg Filmdragerad tablett

Kraj: Szwecja

Język: szwedzki

Źródło: Läkemedelsverket (Medical Products Agency)

Pobierz Ulotka dla pacjenta (PIL)
21-04-2018

Składnik aktywny:

levetiracetam

Dostępny od:

Alfred E Tiefenbacher (GmbH & Co. KG)

Kod ATC:

N03AX14

INN (International Nazwa):

levetiracetam

Dawkowanie:

750 mg

Forma farmaceutyczna:

Filmdragerad tablett

Skład:

levetiracetam 750 mg Aktiv substans; para-orange aluminiumlack Hjälpämne

Klasa:

Apotek

Typ recepty:

Receptbelagt

Dziedzina terapeutyczna:

Levetiracetam

Status autoryzacji:

Avregistrerad

Data autoryzacji:

2012-04-12

Ulotka dla pacjenta

                                PACKAGE LEAFLET: INFORMATION FOR THE
PATIENT
LEVETIFI 250 MG FILM-COATED TABLETS
LEVETIFI 500 MG FILM-COATED TABLETS
LEVETIFI 750 MG FILM-COATED TABLETS
LEVETIFI 1000 MG FILM-COATED TABLETS
levetiracetam
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU OR YOUR CHILD START
TAKING THIS MEDICINE
BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU.
-
Keep this leaflet. You may need to read it again.
-
If you have any further questions, ask your doctor or pharmacist.
-
This medicine has been prescribed for you only. Do not pass it on to
others. It may harm
them, even if their signs of illness are the same as yours.
-
If you get any side effects, talk to your doctor or pharmacist. This
includes any possible
side effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET:
1.
What Levetifi is and what it is used for
2.
What you need to know before you take Levetifi
3.
How to take Levetifi
4.
Possible side effects
5.
How to store Levetifi
6.
Contents of the pack and other information
1.
WHAT LEVETIFI IS AND WHAT IT IS USED FOR
Levetiracetam is an antiepileptic medicine (a medicine used to treat
seizures in epilepsy).
Levetifi is used:

on its own in adults and adolescents from 16 years of age with newly
diagnosed
epilepsy, to treat a certain form of epilepsy. Epilepsy is a condition
where the patients
have repeated fits (seizures). Levetiracetam is used for the epilepsy
form in which the
fits initially affect only one side of the brain, but could thereafter
extend to larger
areas on both sides of the brain (partial onset seizure with or
without secondary
generalisation). Levetiracetam has been given to you by your doctor to
reduce the
number of fits.

as an add-on to other antiepileptic medicines to treat:

partial onset seizures with or without generalisation in adults,
adolescents, children
and infants from one month of age;

myoclonic seizures (short, shock-like jerks of a muscle or group of
muscles) in
adults and adolescents from 12 years of age with juvenile myoclonic
epilepsy;

primary gene
                                
                                Przeczytaj cały dokument
                                
                            

Charakterystyka produktu

                                MARKNADSFÖRS EJ FÖR NÄRVARANDE.
_Produktinformation_
                                
                                Przeczytaj cały dokument
                                
                            

Dokumenty w innych językach

Ulotka dla pacjenta Ulotka dla pacjenta angielski 14-06-2019
Charakterystyka produktu Charakterystyka produktu angielski 14-06-2019
Sprawozdanie z oceny publicznego Sprawozdanie z oceny publicznego angielski 04-02-2013